Diagnostic role of polymerase chain reaction in bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in immunocompromised patients - A retrospective cohort study

被引:9
作者
Hardak, Emilia [1 ,6 ]
Fuchs, Eyal [1 ,6 ]
Leskes, Hannah [4 ]
Geffen, Yuval [5 ]
Zuckerman, Tsila [3 ,6 ]
Oren, Ilana [2 ,3 ,6 ]
机构
[1] Rambam Hlth Care Campus, Div Pulm Med, POB 9602, IL-31096 Haifa, Israel
[2] Rambam Hlth Care Campus, Div Infect Dis, Haifa, Israel
[3] Rambam Hlth Care Campus, Dept Hematol & Bone Marrow Transplantat, Haifa, Israel
[4] Assuta Ashdod Med Ctr, Lab Div, Ashdod, Israel
[5] Rambam Hlth Care Campus, Clin Microbiol Lab, Haifa, Israel
[6] Technion Israely Inst Technol, Bruce Rappaport Fac Med, Haifa, Israel
关键词
PCR; Bronchoalveolar lavage; Diagnosis; Invasive pulmonary aspergillosis; LATERAL-FLOW DEVICE; BETA-D-GLUCAN; FUNGAL-INFECTIONS; HEMATOLOGICAL PATIENTS; PCR ASSAY; GALACTOMANNAN; SAMPLES; PERFORMANCE; THERAPY; DISEASE;
D O I
10.1016/j.ijid.2019.03.025
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: This study aimed to evaluate the diagnostic role of PCR detection of Aspergillus DNA in the broncho-alveolar lavage (BAL) fluid in a large cohort of patients suspected to have invasive pulmonary aspergillosis (IPA). Methods: Consecutive immunocompromised patients who underwent bronchoscopy with BAL sampling and PCR detection of Aspergillus DNA for the diagnosis of pulmonary infiltrates were included in the study. Galactomannan (GM) antigen testing in BAL and serum and BAL fungal culture were also performed. Patients were classified as having IPA (proven/probable/possible) or no-IPA according to the EORTC/MSG diagnostic criteria. Results: During 12 years (2005-2016), 1248 bronchoscopies were performed for 1072 patients. 77% had hematological malignancy, of them 40% had AML and 35.6% underwent HSCT. IPA was diagnosed in 531 patients (42.5%), 7-proven, 280-probable and 244-possible. PCR was positive in 266 cases, of them 213 had IPA, indicating a true positive rate of 80% (213/266) and a false positive rate of 20% (53/266). These results establish the diagnostic performance of PCR to have sensitivity of 40%, specificity of 93%, PPV-80% and NPV-68%. Of 244 patients with possible IPA, 80 had positive PCR. Including PCR in the diagnostic criteria would move 80 cases from the possible group to the probable one. A combination of positive PCR and/or BAL-GM increases sensitivity to 74%, while positivity of both tests elevates PPV to 99.4%. Conclusions: Inclusion PCR for the detection of Aspergillus-DNA in BAL in the mycological criteria of the EORTC/MSG definitions increases the rate and the certainty of IPA diagnosis. (c) 2019 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
引用
收藏
页码:20 / 25
页数:6
相关论文
共 31 条
[1]   Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus [J].
Ascioglu, S ;
Rex, JH ;
de Pauw, B ;
Bennett, JE ;
Bille, J ;
Crokaert, F ;
Denning, DW ;
Donnelly, JP ;
Edwards, JE ;
Erjavec, Z ;
Fiere, D ;
Lortholary, O ;
Maertens, J ;
Meis, JF ;
Patterson, TF ;
Ritter, J ;
Selleslag, D ;
Shah, PM ;
Stevens, DA ;
Walsh, TJ .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (01) :7-14
[2]   Diagnostic Accuracy of PCR Alone Compared to Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis: a Systematic Review [J].
Avni, Tomer ;
Levy, Itzhak ;
Sprecher, Hannah ;
Yahav, Dafna ;
Leibovici, Leonard ;
Paulf, Mical .
JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (11) :3652-3658
[3]   Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study [J].
Boch, T. ;
Spiess, B. ;
Cornely, O. A. ;
Vehreschild, J. J. ;
Rath, P. M. ;
Steinmann, J. ;
Heinz, W. J. ;
Hahn, J. ;
Krause, S. W. ;
Kiehl, M. G. ;
Egerer, G. ;
Liebregts, T. ;
Koldehoff, M. ;
Klein, M. ;
Nolte, F. ;
Mueller, M. C. ;
Merker, N. ;
Will, S. ;
Mossner, M. ;
Popp, H. ;
Hofmann, W-K. ;
Reinwald, M. ;
Buchheidt, D. .
CLINICAL MICROBIOLOGY AND INFECTION, 2016, 22 (10) :862-868
[4]   Aspergillus-PCR in bronchoalveolar lavage for detection of invasive pulmonary aspergillosis in immunocompromised patients [J].
Buess, Michael ;
Cathomas, Gieri ;
Halter, Joerg ;
Junker, Lilian ;
Grendelmeier, Peter ;
Tamm, Michael ;
Stolz, Daiana .
BMC INFECTIOUS DISEASES, 2012, 12
[5]  
Chamilos G, 2006, HAEMATOL-HEMATOL J, V91, P986
[6]   Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: A 1-year retrospective study of consecutive patients at French transplantation centers [J].
Cordonnier, C ;
Ribaud, P ;
Herbrecht, R ;
Milpied, N ;
Valteau-Couanet, D ;
Morgan, C ;
Wade, A .
CLINICAL INFECTIOUS DISEASES, 2006, 42 (07) :955-963
[7]   Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients:: A 6-year survey [J].
Cornillet, A. ;
Camus, C. ;
Nimubona, S. ;
Gandemer, V. ;
Tattevin, P. ;
Belleguic, C. ;
Chevrier, S. ;
Meunier, C. ;
Lebert, C. ;
Aupee, M. ;
Caulet-Maugendre, S. ;
Faucheux, M. ;
Lelong, B. ;
Leray, E. ;
Guiguen, C. ;
Gangneux, J. -P. .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (05) :577-584
[8]   Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group [J].
De Pauw, Ben ;
Walsh, Thomas J. ;
Donnelly, J. Peter ;
Stevens, David A. ;
Edwards, John E. ;
Calandra, Thierry ;
Pappas, Peter G. ;
Maertens, Johan ;
Lortholary, Olivier ;
Kauffman, Carol A. ;
Denning, David W. ;
Patterson, Thomas F. ;
Maschmeyer, Georg ;
Bille, Jacques ;
Dismukes, William E. ;
Herbrecht, Raoul ;
Hope, William W. ;
Kibbler, Christopher C. ;
Kullberg, Bart Jan ;
Marr, Kieren A. ;
Munoz, Patricia ;
Odds, Frank C. ;
Perfect, John R. ;
Restrepo, Angela ;
Ruhnke, Markus ;
Segal, Brahm H. ;
Sobel, Jack D. ;
Sorrell, Tania C. ;
Viscoli, Claudio ;
Wingard, John R. ;
Zaoutis, Theoklis ;
Bennett, John E. .
CLINICAL INFECTIOUS DISEASES, 2008, 46 (12) :1813-1821
[9]   Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis [J].
Eigl, Susanne ;
Hoenigl, Martin ;
Spiess, Birgit ;
Heldt, Sven ;
Prattes, Juergen ;
Neumeister, Peter ;
Wolfler, Albert ;
Rabensteiner, Jasmin ;
Prueller, Florian ;
Krause, Robert ;
Reinwald, Mark ;
Flick, Holger ;
Buchheidt, Dieter ;
Boch, Tobias .
MEDICAL MYCOLOGY, 2017, 55 (05) :528-534
[10]   Improving the diagnosis of invasive aspergillosis by the detection of Aspergillus in broncho-alveolar lavage fluid: Comparison of non-culture-based assays [J].
Guegan, Helene ;
Robert-Gangneux, Florence ;
Camus, Christophe ;
Belaz, Sorya ;
Marchand, Tony ;
Baldeyrou, Marion ;
Gangneux, Jean-Pierre .
JOURNAL OF INFECTION, 2018, 76 (02) :196-205